BIO 2016 Notebook: Pricing And Innovation Hot Topics In San Francisco

Scrip spoke with several executives and attended multiple panel discussions in San Francisco during the first full day of BIO's annual international gathering. Drug pricing and enabling innovation emerged as key themes.

conveyer

Biopharma executives were hammered with questions about drug pricing concerns in the US during January's 34th Annual J.P. Morgan Healthcare Conference in San Francisco and now – five months later in the same city for the Biotechnology Innovation Organization (BIO) International Convention – they appear prepared to strike back with a united message: all stakeholders must work together.

OncoMed Pharmaceuticals Inc. Chairman and CEO Paul Hastings, who is a member of BIO's executive committee and vice chair...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip